Sanofi earns soar on lower restructuring costs (Update)
French drug maker Sanofi said Thursday its earnings soared in the fourth quarter as lower restructuring costs offset a hefty charge related to one of its key multiple sclerosis treatments.
Feb 6, 2014
0
0